HOSPIRA FDA Approval ANDA 088804

ANDA 088804

HOSPIRA

FDA Drug Application

Application #088804

Application Sponsors

ANDA 088804HOSPIRA

Marketing Status

Discontinued001

Application Products

001INJECTABLE;INJECTION100MG/ML0TRIMETHOBENZAMIDE HYDROCHLORIDETRIMETHOBENZAMIDE HYDROCHLORIDE

FDA Submissions

ORIG1AP1987-04-03
LABELING; LabelingSUPPL2AP1988-10-17
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1990-01-03
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1990-03-26
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1995-12-22
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1997-01-16
MANUF (CMC); Manufacturing (CMC)SUPPL8AP2000-09-05
MANUF (CMC); Manufacturing (CMC)SUPPL9AP2001-02-14

Submissions Property Types

ORIG1Null0
SUPPL2Null0
SUPPL3Null0
SUPPL4Null0
SUPPL6Null0
SUPPL7Null0
SUPPL8Null0
SUPPL9Null0

CDER Filings

HOSPIRA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 88804
            [companyName] => HOSPIRA
            [docInserts] => ["",""]
            [products] => [{"drugName":"TRIMETHOBENZAMIDE HYDROCHLORIDE","activeIngredients":"TRIMETHOBENZAMIDE HYDROCHLORIDE","strength":"100MG\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"TRIMETHOBENZAMIDE HYDROCHLORIDE","submission":"TRIMETHOBENZAMIDE HYDROCHLORIDE","actionType":"100MG\/ML","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.